HealthyDirect · GrowthFit for a long SIP
PGIM India Small Cap Fund
PGIM India Mutual FundEquity Scheme - Small Cap Fund5.3 years
The scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of small cap companies.
- NAV
- 19.57
- 4 Nov 2026
- 1Y
- +9.5%
- Trailing CAGR
- Upside capture
- +84%
- Vs NIFTY SMALLCAP 250 TRI
- Downside capture
- +80%
- Lower is better
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 4 Nov 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · Three-year return is above the category median.
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Buy checklist
History depth
Pass
5.3 years of path to read.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.93% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -24.6%. Ask whether you can hold through a similar fall.
Vs category
Fail
9% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Utsav Mehta · 2.6 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 28.1% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 25%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+9.5%
- 3Y+15.4%
- 5Y+11.7%
- 10Yn/a
- SI+13.3%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+18.3%
- 3Y+12.4%
- 5Y+14.0%
- 10Yn/a
- Since inception
- +13.3%
- Calendar-day CAGR
- Excess 1Y
- +5.3%
- Category median, same plan and option
- 3Y win rate
- +9%
- Windows beating the median
- 3Y percentile
- 67
- Vs comparable share classes
- SIP 3Y XIRR
- +12.4%
- Simulated monthly SIP
- Worst rolling 3Y
- +7.8%
- 558 daily-ending windows
- Median rolling 3Y
- +16.0%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 65 daily-ending windows
Official benchmark
Date-aligned against NIFTY SMALLCAP 250 TRI. Capture ratios use common month-end observations through 5 Nov 2026.
- 1Y excess
- +8.5%
- Fund minus TRI
- 3Y excess
- +2.3%
- Fund minus TRI
- Upside capture
- +84%
- Benchmark-up months
- Downside capture
- +80%
- Lower is better
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -24.6%
- Worst peak-to-trough
- Current
- -4.5%
- Below last peak
- Current spell
- 65 days
- Days below latest peak
- Time below peak
- +88%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 18 days
- 54 recovered episodes
- Longest recovery
- 392 days
- Trough to prior peak
17 Jan 2022 – 17 Jul 2023
Trough 20 Jun 2022 · recovered in 392 days
-24.6%
16 Oct 2024 – 17 Sept 2025
Trough 3 Mar 2025 · recovered in 198 days
-21.5%
19 Sept 2025 – 7 May 2026
Trough 23 Mar 2026 · recovered in 45 days
-16.2%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-10.7%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
67
Vs category
83
Consistency
23
Risk-adjusted
51
Drawdown
39
Mean
53
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 73 holdings · top 10 are 28.1%.
- Top 5
- 15.9%
- Top 10
- 28.1%
- Largest holding
- 3.5%
- Effective holdings
- 57.8
Others CBLO
Unspecified
3.5%
Sansera Engineering Ltd
Consumer Discretionary
3.4%
TBO Tek Ltd.
Consumer Discretionary
3.1%
SEDEMAC Mechatronics Ltd.
Industrials
3.0%
Krishna Institute Of Medical Sciences Ltd
Healthcare
2.9%
What changed
DECISION
Status moved from MONITOR to HEALTHY.
22 Sept 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
BANDHAN Small Cap Fund
Bandhan Mutual Fund
- 1Y
- +4.4%
- 3Y
- +22.3%
- Vol
- 17.2%
- Max DD
- -24.3%
- Sharpe
- 1.25
- 3Y win
- +76%
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility
TRUSTMF SMALL CAP FUND
Trust Mutual Fund
- 1Y
- +21.0%
- 3Y
- n/a
- Vol
- 18.6%
- Max DD
- -24.0%
- Sharpe
- 0.60
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Higher TER
BANK OF INDIA SMALL CAP FUND
Bank of India Mutual Fund
- 1Y
- +20.6%
- 3Y
- +19.3%
- Vol
- 18.1%
- Max DD
- -32.4%
- Sharpe
- 1.10
- 3Y win
- +84%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
DSP Small Cap Fund
DSP Mutual Fund
- 1Y
- +12.2%
- 3Y
- +16.7%
- Vol
- 16.5%
- Max DD
- -49.1%
- Sharpe
- 0.91
- 3Y win
- +30%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
ITI Small Cap Fund
ITI Mutual Fund
- 1Y
- +14.3%
- 3Y
- +22.2%
- Vol
- 20.1%
- Max DD
- -39.9%
- Sharpe
- 0.80
- 3Y win
- +55%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown